Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | MGTX | Ordinary Shares ($0.00003881 par value per share) | 11.5M | Aug 12, 2024 | Through its wholly-owned subsidiary, Sanofi Foreign Participations B.V. | F1 | |||||
holding | MGTX | Ordinary Shares ($0.00003881 par value per share) | 698K | Aug 12, 2024 | Through its wholly-owned subsidiary Kadmon Corporation, LLC | F1 |
Id | Content |
---|---|
F1 | Sanofi is the beneficial owner of Ordinary Shares of the Issuer through its wholly owned subsidiaries Sanofi Foreign Participations B.V. and Kadmon Corporation, LLC. |